Glucose Intolerance and Associated Factors in the Multi-ethnic Population of the United Arab Emirates: Results of a National Survey
Overview
Authors
Affiliations
Aims: To determine the prevalence of diabetes and impaired fasting glycaemia (IFG) and associated conditions such as obesity and hypertension, in the multi-ethnic, adult population of the United Arab Emirates in 1999-2000.
Methods: A stratified, multistage, random sample was selected. Diagnosis was based on the latest recommendations of a WHO Expert Group.
Results: The overall response rate was 89%. Crude prevalence of diabetes was 20%. It was higher in UAE citizens (25%) than in expatriates (13-19% depending on country of origin). Prevalence of diabetes rose with age to a maximum of 40% after the age of 55 years. Prevalence of impaired fasting glycaemia was 5% in men and 7% in women. Forty-one percent of subjects with diabetes were undiagnosed prior to the survey. Of the previously diagnosed subjects with diabetes, 59% were taking oral hypoglycaemic agents, 8% used insulin and 17% relied on diet alone. Obesity was common in all ethnic groups. Approximately three-quarters of all subjects were either obese (BMI> or =30) or overweight (BMI 25-29). Presence of diabetes was associated with increasing waist-hip ratio (WHR), age and with systolic blood pressure and ethnicity. Co-morbidity with glucose intolerance occurred with obesity in 8% and with hypertension in 5%. Three-quarters of all subjects had one or more of these conditions.
Conclusions: Diabetes, obesity and hypertension are extremely prevalent in the adult population of the UAE. Prompt action is required to avert a major public health crisis due to the long-term complications of diabetes in the near future.
Aldahash R, Batais M, El-Metwally A, Alhosan S, Alharbi M, Almutairi M Clin Pract. 2025; 15(1).
PMID: 39851792 PMC: 11763823. DOI: 10.3390/clinpract15010009.
Gariballa S, Al-Bluwi G, Yasin J Nutrients. 2024; 16(23).
PMID: 39683438 PMC: 11643926. DOI: 10.3390/nu16234044.
Shahrestanaki E, Mohammadian Khonsari N, Seif E, Baygi F, Ejtahed H, Sheidaei A Front Public Health. 2024; 12:1305304.
PMID: 38827607 PMC: 11140097. DOI: 10.3389/fpubh.2024.1305304.
Aljehani R, Aljehani G, Alharazi H, Ghisi G PEC Innov. 2023; 3:100205.
PMID: 37700765 PMC: 10494255. DOI: 10.1016/j.pecinn.2023.100205.
Gariballa S, Al-Bluwi G, Yasin J Antioxidants (Basel). 2023; 12(4).
PMID: 37107201 PMC: 10135384. DOI: 10.3390/antiox12040826.